effectiveness of tirzepatide vs semaglutide Frontiers comparative effectiveness of semaglutide and

Compounded semaglutide that has been left at room temperature overnight should not be used due to potential degradation and safety concerns

Common AEs were nausea (23%), vomiting (6%), diarrhea (6%), constipation (10%), headache (6%), fatigue (8%), abdominal pain (2%), and abdominal bloating (2%)

A new multinational study says probably not

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among people with obesity

- 7.2% of GLP-1 users received a gout diagnosis, compared with 6.6% of nonusersabout a 12% higher risk

A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists medications that are widely prescribed for metabolic disease have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.